compounded semaglutide overdose GLP-1 Drug 13 Investigates: Family recounts 7-year-old's

Szkudelski T

Patients who are already on basal insulin like Lantus and want a more concentrated option with potentially fewer injection-site reactions and slightly lower hypoglycemia risk

Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice

In the Phase III trial, enlicitide not only lowered LDL cholesterol significantly more than oral medications developed since statins but also reduced other cardiovascular risk markers like non-HDL cholesterol and apolipoprotein B, with sustained effects for a year

At the class level, both have a GI-dominant profile (nausea, vomiting, diarrhoea) that concentrates at dose escalation

Similar principles apply to other GLP-1 medications, which is helpful to know if you are considering options or reading about topics like understanding side effects when starting GLP-1 treatment